risperidone has been researched along with Idiopathic Parkinson Disease in 37 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This pilot study investigated effectiveness and tolerability of risperidone for the treatment of psychosis and agitation in 9 inpatients with Parkinson's disease and dementia." | 5.08 | The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. ( Bakey, AA; Kunik, ME; Molinari, VA; Orengo, CA; Workman, RH, 1997) |
| "Risperidone, a novel neuroleptic with approximately equal D2 and 5HT2A receptor blocking properties, has been used to treat drug-related hallucinations in patients with Parkinson's disease." | 3.70 | Risperidone treatment of drug-related psychosis in patients with parkinsonism. ( Leopold, NA, 2000) |
| "We present a case in which the use of low dose risperidone (a potent D2 and 5-HT2 antagonist) was successful in controlling gambling behaviour secondary to dopamine agonist treatment of Parkinson's disease." | 3.70 | Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. ( Kesler, S; Niehaus, DJ; Seedat, S; Stein, DJ, 2000) |
| "Although the mean motor Unified Parkinson's Disease Rating Scale score worsened in the risperidone group and improved in the clozapine group, this difference did not reach statistical significance." | 2.69 | Clozapine and risperidone treatment of psychosis in Parkinson's disease. ( Cudkowicz, ME; Ellis, T; Growdon, JH; Sexton, PM, 2000) |
| "Risperidone treatment did not adversely affect symptoms specific to Parkinson's disease, as assessed by the Unified Parkinson's Disease Rating Scale (UPDRS)." | 2.69 | Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial. ( De Deyn, PP; Hildebrand, K; Mendis, T; Mohr, E, 2000) |
| "Hallucinations and psychosis are common in patients with Parkinson's disease (PD), with reported prevalences of up to 48% and 80%, respectively." | 2.46 | Management of hallucinations and psychosis in Parkinson's disease. ( Eng, ML; Welty, TE, 2010) |
| "2." | 2.39 | Psychosis in Parkinson's disease: diagnosis and treatment. ( Deveaugh-Geiss, J; Doraiswamy, M; Martin, W; Metz, A, 1995) |
| "Though it was difficult to control their visual hallucinations with medication only, cataract surgery made them disappeared quickly." | 1.32 | [Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery]. ( Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (37.84) | 18.2507 |
| 2000's | 18 (48.65) | 29.6817 |
| 2010's | 4 (10.81) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Lilja, S | 1 |
| Tolppanen, AM | 1 |
| Koponen, M | 1 |
| Hartikainen, S | 1 |
| Tiihonen, M | 1 |
| Wilby, KJ | 1 |
| Johnson, EG | 1 |
| Johnson, HE | 1 |
| Ensom, MHH | 1 |
| Iketani, R | 1 |
| Imai, S | 1 |
| Horiguchi, H | 1 |
| Furushima, D | 1 |
| Fushimi, K | 1 |
| Yamada, H | 1 |
| Chen, CK | 1 |
| Wu, JH | 1 |
| Palminteri, S | 1 |
| Lebreton, M | 1 |
| Worbe, Y | 1 |
| Grabli, D | 1 |
| Hartmann, A | 1 |
| Pessiglione, M | 1 |
| Friedman, JH | 6 |
| Eng, ML | 1 |
| Welty, TE | 1 |
| Fernandez, HH | 1 |
| Theodoulou, G | 1 |
| Milner, G | 1 |
| Jumaian, A | 1 |
| Hoeh, N | 1 |
| Gyulai, L | 1 |
| Weintraub, D | 1 |
| Streim, J | 1 |
| Matsui, H | 1 |
| Udaka, F | 1 |
| Oda, M | 1 |
| Kubori, T | 1 |
| Nishinaka, K | 1 |
| Kameyama, M | 1 |
| Baskys, A | 1 |
| Katz, IR | 1 |
| Stein, DJ | 2 |
| Grant, JE | 1 |
| Honer, WG | 1 |
| Kopala, LC | 1 |
| Rabinowitz, J | 1 |
| Rustembegovic, A | 1 |
| Sofic, E | 1 |
| Wichart, I | 1 |
| Chou, KL | 1 |
| Borek, LL | 1 |
| Meco, G | 2 |
| Alessandria, A | 1 |
| Bonifati, V | 2 |
| Giustini, P | 2 |
| Ford, B | 1 |
| Lynch, T | 1 |
| Greene, P | 1 |
| Tavares, AR | 1 |
| McKeith, IG | 1 |
| Ballard, CG | 1 |
| Harrison, RW | 1 |
| Beck, BJ | 1 |
| Stip, E | 1 |
| Tourjman, V | 1 |
| Lew, V | 1 |
| Fabian, J | 1 |
| Cormier, H | 1 |
| Landry, P | 1 |
| Lalonde, P | 1 |
| Cournoyer, J | 1 |
| Rich, SS | 1 |
| Ott, BR | 2 |
| Doraiswamy, M | 1 |
| Martin, W | 1 |
| Metz, A | 1 |
| Deveaugh-Geiss, J | 1 |
| Damecour, CL | 1 |
| Turcotte, JR | 1 |
| Alessandri, A | 1 |
| Workman, RH | 1 |
| Orengo, CA | 1 |
| Bakey, AA | 1 |
| Molinari, VA | 1 |
| Kunik, ME | 1 |
| Shiwach, RS | 1 |
| Woods, S | 1 |
| Geizer, M | 1 |
| Ancill, RJ | 1 |
| Leopold, NA | 1 |
| Seedat, S | 1 |
| Kesler, S | 1 |
| Niehaus, DJ | 1 |
| Ellis, T | 1 |
| Cudkowicz, ME | 1 |
| Sexton, PM | 1 |
| Growdon, JH | 1 |
| Mohr, E | 1 |
| Mendis, T | 1 |
| Hildebrand, K | 1 |
| De Deyn, PP | 1 |
| Factor, SA | 1 |
| Molho, ES | 1 |
| Stryjer, R | 1 |
| Bar, F | 1 |
| Strous, RD | 1 |
| Baruch, Y | 1 |
| Rabey, JM | 1 |
9 reviews available for risperidone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parki | 2017 |
Management of hallucinations and psychosis in Parkinson's disease.
Topics: Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Comorbidity; Delusions; Demen | 2010 |
Atypical antipsychotics in Parkinson-sensitive populations.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Dementia, Vascular; Dibenzothia | 2002 |
Pharmacologic management of psychosis in the elderly: a critical review.
Topics: Aged; Alzheimer Disease; Benzodiazepines; Bipolar Disorder; Clozapine; Depressive Disorder; Drug Adm | 2003 |
Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical | 2004 |
Optimizing atypical antipsychotic treatment strategies in the elderly.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Controlled | 2004 |
The management of psychosis in movement disorder patients.
Topics: Antipsychotic Agents; Clozapine; Haloperidol; Humans; Huntington Disease; Lewy Body Disease; Parkins | 2007 |
Neuropsychiatric manifestations of diffuse Lewy body disease.
Topics: Alzheimer Disease; Antipsychotic Agents; Brain Stem; Clozapine; Dopamine Antagonists; Humans; Lewy B | 1995 |
Psychosis in Parkinson's disease: diagnosis and treatment.
Topics: Clozapine; Diagnosis, Differential; Humans; Parkinson Disease; Psychotic Disorders; Risperidone | 1995 |
5 trials available for risperidone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Double-Bli | 2005 |
Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
Topics: Aged; Antipsychotic Agents; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; | 1997 |
The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
Topics: Aged; Antipsychotic Agents; Dementia; Female; Humans; Male; Parkinson Disease; Pilot Projects; Psych | 1997 |
Clozapine and risperidone treatment of psychosis in Parkinson's disease.
Topics: Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Double-Blind Method; Humans; | 2000 |
Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Belgium; Canada; Dopamin | 2000 |
23 other studies available for risperidone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Incidence of antipsychotic use among community dwellers with and without Parkinson's disease.
Topics: Antipsychotic Agents; Cohort Studies; Humans; Incidence; Parkinson Disease; Quetiapine Fumarate; Ris | 2022 |
Comparison of the association of risperidone and quetiapine with deteriorating performance in walking and dressing in subjects with Parkinson's disease: a retrospective cohort study using administrative claims data.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Cohort Studies; Female; Humans; Male; Parkinson | 2019 |
Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Middle Aged; Parkinson | 2009 |
Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.
Topics: Adolescent; Adult; Avoidance Learning; Conditioning, Psychological; Cues; Dopamine Agonists; Dopamin | 2009 |
Recommendations on the drug treatment of psychosis in Parkinson's disease.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Parkinson Disease; Psychotic Disorders; Quetiapine | 2010 |
Neuroleptics and family history of Parkinson diseases: case report.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Depressive Disorder; Diagnostic Errors; Female; | 2001 |
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levo | 2004 |
Betting on dopamine.
Topics: Antipsychotic Agents; Brain; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impu | 2005 |
Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.
Topics: Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Dibenzothiazepines; Hu | 2006 |
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
Topics: Aged; Antipsychotic Agents; Hallucinations; Humans; Isoxazoles; Levodopa; Parkinson Disease; Piperid | 1994 |
Risperidone in Parkinson's disease.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Psychotic Disorders; Rispe | 1994 |
Risperidone in Parkinson's disease.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Risperidone | 1995 |
Neuroleptic sensitivity to risperidone in Lewy body dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Dementia; Female; Humans; Iso | 1995 |
"Awakenings" effect with risperidone.
Topics: Antipsychotic Agents; Drug Administration Schedule; Humans; Parkinson Disease; Psychotic Disorders; | 1995 |
Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
Topics: Aged; Antiparkinson Agents; Clozapine; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease; Pa | 1995 |
Therapeutic dilemma: psychosis and Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lev | 1995 |
Risperidol and withdrawal bruxism in Lewy body dementia.
Topics: Aged; Antipsychotic Agents; Bruxism; Delusions; Dopamine Antagonists; Humans; Male; Parkinson Diseas | 1998 |
Combination of risperidone and donepezil in Lewy body dementia.
Topics: Aged; Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Therapy, Combinatio | 1998 |
Should risperidone be used in Parkinson's disease?
Topics: Antipsychotic Agents; Humans; Parkinson Disease; Risperidone | 1998 |
Risperidone treatment of drug-related psychosis in patients with parkinsonism.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Female; Hallucinations; Humans; | 2000 |
Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents.
Topics: Antipsychotic Agents; Carbidopa; Dopamine Agonists; Drug Therapy, Combination; Female; Gambling; Hum | 2000 |
Risperidone and Parkinson's disease.
Topics: Antipsychotic Agents; Humans; Parkinson Disease; Psychotic Disorders; Risperidone | 2002 |
Donepezil management of schizophrenia with associated dementia.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Comorbidity; Dementia; Donepezil; Drug Therapy, Co | 2002 |